surmount 1 tirzepatide nejm In the SURMOUNT-1 trial (published in in July 2022), adults with #obesity treated with weekly tirzepatide, a glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1 receptor Revolutionizing Sleep Apnea Treatment with – Tirzepatide's Surmount-4 Trial Reveals Groundbreaking

Microneedling is minimally invasive, meaning it is a low-risk and generally painless procedure that doesnt disrupt your daily life

The Precision Peptide Genetic Test examines variants in GIPR, FTO, and MC4R, and 10 other pathways affecting your metabolic response

124 A 6-month clinical trial examining the use of CPAP in individuals with obstructive sleep apnea and type 2 diabetes found that patients treated with CPAP experienced greater reductions in glycated hemoglobin levels compared with control patients

Boost Hair Growth & Scalp Health

Recording weight in a log or smartphone application allows patients and clinicians to identify patterns and calculate the rate of weight loss over time